Since we mainly enrolled acral melanoma in our cohorts, which represents the most common subtype in Asians, it is reasonable to believe that CD73 may represent an ideal immunotherapy target next to PD-L1 in melanoma. This evidence concerns the gene NT5E and acral lentiginous melanoma.